Different therapeutic regimens in the treatment of metastatic prostate cancer
Int J Surg
.
2023 Dec 1;109(12):4361-4362.
doi: 10.1097/JS9.0000000000000685.
Authors
Shuai Huang
1
,
Sheng Huang
2
,
Jiangang Pan
3
,
Zhuoyuan Lin
3
,
Yubo Tang
4
,
Qingde Wa
5
Affiliations
1
Department of Orthopaedic Surgery.
2
Department of Orthopaedic Surgery, The First Affiliated Hospital of Nanchang University, Nanchang.
3
Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou.
4
Department of Pharmacy, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou.
5
Department of Orthopaedic Surgery, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou Province, People's Republic of China.
PMID:
38259005
PMCID:
PMC10720866
DOI:
10.1097/JS9.0000000000000685
No abstract available
Publication types
Letter
MeSH terms
Humans
Male
Prostatic Neoplasms* / drug therapy